Journal Articles- Refereed

Brasier, C., Ski, C., Thompson, D., Cameron, J., O’Brien, C., Lautenschlager, N., Gonzales, G., HSUEH, Y.S.A., ... & Rossell, S.L. (2016). The Stroke and Carer Optimal Health Program (SCOHP) to enhance psychosocial health: study protocol for a randomized controlled trial. Trials, 17(1), 446.

Byrnes, J., Shakeshaft, A., PETRIE, D., & Doran, C. M. (2016). Is response to price equal for those with higher alcohol consumption? The European Journal of Health Economics, 17(1), 23-29.

CLARKE, P., & ERREYGERS, G. (2016). Alexander Sutherland: A Forgotten Pioneer of Health Economics in Australia? Australian Economic Review,49(2), 169-173.

CLARKE, P., Herbert, D., Graves, N., & Barnett, A. G. (2016). A randomized trial of fellowships for early career researchers finds a high reliability in funding decisionsJournal of Clinical Epidemiology, 69, 147-151.

Gummer, J., Trengove, R., Pascoe, E, Badve, S., Cass, A., CLARKE, P., ... & Reidlinger, D. (2016). Association between Serum Hepcidin‐25 and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial. Nephrology.

Hayes, A., Arima, H., Woodward, M., Chalmers, J., Poulter, N., Hamet, P., & CLARKE, P. (2016). Changes in quality of life associated with complications of diabetes: results from the ADVANCE study. Value in Health, 19(1), 36-41.

HUA, X., Herman, W. H., & CLARKE, P. (2016). Cost of Antihyperglycemic Medications in the United States--Reply. Journal of the American Medical Association (JAMA), 316(6), 665-666.

HUA, X., CARVALHO, N., TEW, M., Huang, E. S., Herman, W. H., & CLARKE, P. (2016). Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013. JAMA, 315(13), 1400-1402

Knowles, S.R., Ski, C.F., Langham, R., O’Flaherty, E., Thompson, DR., Rossell, S.L., Moore, G., HSUEH, Y.S.A. & Castle, D. J. (2016). Design and protocol for the Dialysis Optimal Health Program (DOHP) randomised controlled trial. Trials, 17(1), 447.

Moayeri, F., HSUEH, Y. S., CLARKE, P., Hua, X., & Dunt, D. (2016). Health State Utility Value in Chronic Obstructive Pulmonary Disease (COPD); The Challenge of Heterogeneity: A Systematic Review and Meta-Analysis. Journal of Chronic Obstructive Pulmonary Disease, 13(3), 380-398.

Moayeri, F., HSUEH, Y., CLARKE, P., & Dunt, D. (2016). Do Model-Based Studies in Chronic Obstructive Pulmonary Disease Measure Correct Values of Utility? A Meta-Analysis. Value in Health.

Nghiem, N., Blakely, T., COBIAC, L., Cleghorn, C., & Wilson, N. (2016). The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects. BMC Public Health, 16(1), 1.

Ong, J. J., Fairley, C. K., Carroll, S., Walker, S., Chen, M., Read, T., ... & CLARKE, P. (2016). Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIVJournal of the International AIDS Society, 19(1).

Payne, C., Scarborough, P., & COBIAC, L. (2016). Do low-carbon-emission diets lead to higher nutritional quality and positive health outcomes? A systematic review of the literature. Public Health Nutrition, 1-8.

Pearson, A. L., Cleghorn, C. L., van der Deen, F., COBIAC, L., Kvizhinadze, G., Nghiem, N., ... & Wilson, N. (2016). Tobacco retail outlet restrictions: health and cost impacts from multistate life-table modelling in a national population. Tobacco Control, tobaccocontrol-2015.

Petrie, D., Lung, T. W., Rawshani, A., Palmer, A. J., Svensson, A. M., Eliasson, B., & CLARKE, P. (2016). Recent trends in life expectancy for people with type 1 diabetes in Sweden. Diabetologia, 59(6), 1167-1176.

Roberts, C., Owen, L., Manley, B., Frøisland, D., Donath, S., DALZIEL, K., Pritchard, M., Cartwright, D., Collins, C. L., Malhotra, A. & Davis, P. G. (2016). Nasal High-Flow Therapy for Primary Respiratory Support in Preterm Infants. New England Journal of Medicine, 375(12), 1142-1151.

Leslie, K., Allen, M., Lee, A., & CLARKE, P. (2016). A randomized-controlled trial of high-or low-volume intravenous Plasma-Lyte® to prevent hypotension during sedation for colonoscopyCanadian Journal of Anesthesia/Journal Canadien d'Anesthésie, 1-10.

SCHILLING, C., DALZIEL, K., Nunn, R., Du Plessis, K., Shi, W. Y., Celermajer, D., ... & Bullock, A. (2016). The Fontan epidemic: Population projections from the Australia and New Zealand Fontan RegistryInternational journal of Cardiology219, 14-19.

SCHILLING, C., Dowsey, M., CLARKE, P., & Choong, P. (2016). Using Patient-Reported Outcomes for Economic Evaluation: Getting the Timing Right. Value in Health.

SCHILLING, C, Dowsey, M., Petrie, D., CLARKE, P, & Choong, P. (2016). Predicting the Long-Term Gains in Health-Related Quality of Life After Total Knee Arthroplasty. The Journal of Arthroplasty.

SCHILLING, C., Mortimer, D., & DALZIEL, K. (2016). Using CART to Identify Thresholds and Hierarchies in the Determinants of Funding Decisions. Medical Decision Making, 0272989X16638846.

SCHILLING, C., Mortimer, D., DALZIEL, K., Heeley, E., Chalmers, J., & CLARKE, P. (2016). Using Classification and Regression Trees (CART) to identify prescribing thresholds for cardiovascular disease. PharmacoEconomics,34(2), 195-205.

SCHILLING, C., PETRIE, D., Dowsey, M. M., Choong, P. F., & CLARKE, P. (2016). The Impact of Regression to the Mean on Economic Evaluation in Quasi‐Experimental Pre–Post Studies: The Example of Total Knee Replacement Using Data from the Osteoarthritis InitiativeHealth Economics.

Sutton, K., Isaacs, A. N., DALZIEL, K., & Maybery, D. (2016). Roles and competencies of the Support Facilitator in Australia’s recovery-oriented mental health initiative: a qualitative study from Gippsland, Victoria. Australian Health Review.

TRAN-DUY, A., Spaetgens, B., Hoes, A. W., de Wit, N. J., & Stehouwer, C. D. (2016). Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 14(12), 1706-1719.

Wilson, T.G., Iyengar, A.J., Winlaw, D.S., Weintraub, R.G., Wheaton, G.R., Gentles, T.L., Ayer, J., Grigg, L.E., Justo, R.N., Radford, D.J., Bullock, A., Celermajer, D.S., DALZIEL, K., SCHILLING, C., & d'Udekem, Y. (2016). Use of ACE inhibitors in Fontan: Rational or irrational? International Journal of Cardiology210, 95-99.

Wilson, N., Nghiem, N., Eyles, H., Mhurchu, C., Shields, E., COBIAC, L., ... & Blakely, T. (2016). Modeling health gains and cost savings for ten dietary salt reduction targets. Nutrition journal, 15(1), 1.

Wilson, N., Selak, V., Blakely, T., Leung, W., CLARKE, P., Jackson, R., KNIGHT, J., Nghiem, N. (2016). Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators. New Zealand Medical Journal, 129(1431), 85-92.

Wolowacz, S. E., Briggs, A., Belozeroff, V., CLARKE, P., Doward, L., Goeree, R., ... & Norman, R. (2016). Estimating health-state utility for economic models in clinical studies: an ISPOR Good Research Practices Task Force Report. Value in Health, 19(6), 704-719.

Zhang, L., Coombes, J., Pascoe, E. M., Badve, S. V., DALZIEL, K., Cass, A., ... & Pedagogos, E. (2016). The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial. Redox Report, 21(1), 14-23.